You are right that this is a much better approach. The problem is Europe also has low sperm counts and are also being exposed to endocrine disruptors in the same way as the rest of the world. So whatever whitelist approach they are using does not seem to be saving them from this problem.
There's however a huge difference in what's being actually prescribed and what's not. Anti-Depressants and strong pain medication isn't as easy to get as in the us as in Germany.
